Patent: 4,170,639
Summary for Patent: 4,170,639
| Title: | Antihemophilic factor concentrate and its production |
| Abstract: | Antihemophilic factor (AHF) concentrate having enhanced potency and solubility and its process of production are provided. The process includes the steps of removing unwanted protein from an aqueous extract of antihemophilic blood plasma cryoprecipitate by mixing the aqueous extract with aluminum hydroxide at an acid pH in the cold, adjusting the purified aqueous extract to an acid pH and freeze-drying the extract, optionally removing water from the extract just before freeze-drying. |
| Inventor(s): | Daniel T. H. Liu, John F. Irwin, Rong-Chang Pai |
| Assignee: | Oesterreichisches Institut fuer Haemoderivate |
| Application Number: | US05/923,139 |
| Patent Claims: | see list of patent claims |
Details for Patent 4,170,639
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Csl Behring Llc | MONOCLATE, MONOCLATE-P | antihemophilic factor (human) | For Injection | 103953 | May 14, 2003 | ⤷ Start Trial | 1998-07-10 |
| Csl Behring Llc | MONOCLATE, MONOCLATE-P | antihemophilic factor (human) | For Injection | 103953 | March 4, 2004 | ⤷ Start Trial | 1998-07-10 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
